| Forms of extracellular mitochondria and their impact in health S Miliotis, B Nicolalde, M Ortega, J Yepez, A Caicedo Mitochondrion 48, 16-30, 2019 | 116 | 2019 |
| Publication rate and citation counts for preprints released during the COVID-19 pandemic: the good, the bad and the ugly D Añazco, B Nicolalde, I Espinosa, J Camacho, M Mushtaq, J Gimenez, ... PeerJ 9, e10927, 2021 | 56 | 2021 |
| Psychiatric disorders in Post-acute COVID-syndrome (PDPACS): recommendations for health care professionals AF Paez, B Nicolalde, C Esquetini-Vernon, Y Lara-Taranchenko, ... European Neuropsychopharmacology 58, 100, 2022 | 6 | 2022 |
| The Role of Telemedicine on Ecuador During the COVID-19 Crisis: A Perspective from a Volunteer Physician B Nicolalde International Journal of Medical Students 8 (2), 154-155, 2020 | 6 | 2020 |
| Current pharmacological therapy against COVID-19: a latin american perspective B Nicolalde, D Añazco, M Mushtaq, A Aguilar, E Terán Latin American Journal of Clinical Sciences and Medical Technology 2 (2), 59-68, 2020 | 6 | 2020 |
| Cognitive impairment or dementia in post-acute COVID-19 syndrome. Two suspects and a perfect detective: positron emission tomography (PET) scan M Vélez, AF Paez, B Nicolalde, C Esquetini-Vernon, Y Lara-Taranchenko, ... European Neuropsychopharmacology 61, 91, 2022 | 4 | 2022 |
| Citations and publication rate of preprints on pharmacological interventions for COVID-19: The good, the bad and, the ugly. B Nicolalde, D Añazco, M Mushtaq, I Espinosa, J Gimenez, E Teran | 4 | 2020 |
| Quantifying alcohol use among Ecuadorian human immunodeficiency virus positive individuals and assessing alcohol as an independent risk factor for human immunodeficiency virus … JM Downen, B Swendener, AA Bodlak, DF Añazco, BI Nicolalde, ... Medicine 99 (48), e23276, 2020 | 3 | 2020 |
| Weight loss and cardiovascular disease risk outcomes of semaglutide: a one-year multicentered study W Ghusn, S Fansa, D Anazco, E Tama, B Nicolalde, K Gala, A De la Rosa, ... International Journal of Obesity, 1-6, 2024 | 2 | 2024 |
| FRI077 Efficacy of anti-obesity medications among breast cancer survivors taking aromatase inhibitors S Fansa, W Ghusn, E Tama, B Nicolalde, D Anazco, S D'Andre, S Faubion, ... Journal of the Endocrine Society 7 (Supplement_1), bvad114. 087, 2023 | 1 | 2023 |
| The time to act: Early recommendations on patient care for psychiatric disorders in post-acute COVID-19 syndrome (PDPACS); Response to Llach and Ammella´ s letter to the editor … AF Paez, B Nicolalde, C Esquetini-Vernon, Y Lara-Taranchenko, ... European Neuropsychopharmacology 60, 89, 2022 | 1 | 2022 |
| Scientific literacy and preferred resources used by latin American medical students during the COVID-19 pandemic: a multinational survey B Nicolalde, D Añazco, MJ Jaramillo-Cartwright, I Salinas, ... F1000Research 11, 2022 | 1 | 2022 |
| Efficacy of Antiobesity Medications in Patients With Celiac Disease on a Gluten-free Diet: A Retrospective Matched Cohort Study D Anazco, S Fansa, W Ghusn, K Gala, B Nicolalde, E Tama, G Calderon, ... Journal of Clinical Gastroenterology 58 (7), 650-655, 2024 | | 2024 |
| Mo1950 COMPARATIVE EFFICACY OF ENDOSCOPIC SUBMUCOSAL DISSECTION AND ANTI-OBESITY MEDICATIONS IN MANAGING WEIGHT RECURRENCE POST-ROUX-EN-Y GASTRIC BYPASS VIA TRANSORAL OUTLET … S Fansa, W Ghusn, K Gala, MG Keane, DM Abboud, K Al Annan, ... Gastroenterology 166 (5), S-1185-S-1186, 2024 | | 2024 |
| Rhupus syndrome in the pediatric population: A comprehensive systematic literature review. M Velez-Arteaga, GC Carrera-Barriga, K Moreno-Montenegro, C Gallegos, ... Medicine 103 (14), e36451, 2024 | | 2024 |
| The Effect of Altitude on Cardiovascular Disease Mortality: Insights From a National Database in Ecuador B Nicolalde, F Serpa, DM Velez Arteaga, AN Caputi Zuniga, X Arias, ... Circulation 148 (Suppl_1), A12815-A12815, 2023 | | 2023 |
| The Individualized Metabolic Surgery Score Predicts Weight Loss in Patients with T2DM on Semaglutide W Ghusn, S Fansa, D Anazco, E Tama, B Nicolalde, K Gala, L Cifuentes, ... OBESITY 31, 82-83, 2023 | | 2023 |
| S1485 Semaglutide Outcomes in Non-Alcoholic Fatty Liver Disease: A Multi-Centered Real-World Study W Ghusn, S Fansa, D Anazco, E Tama, B Nicolalde, K Gala, L Cifuentes, ... Official journal of the American College of Gastroenterology| ACG 118 (10S …, 2023 | | 2023 |
| S1648 Cardiovascular Disease Risk Improvement With Semaglutide in Patients With Obesity: A Multi-Centered Study W Ghusn, D Anazco, S Fansa, E Tama, A De La Rosa, B Nicolalde, ... Official journal of the American College of Gastroenterology| ACG 118 (10S …, 2023 | | 2023 |
| FRI078 Real-World Weight Loss Outcomes And Safety Of Tirzepatide, A Novel Dual GIP And GLP-1 Receptor Agonist S Fansa, W Ghusn, B Nicolalde, D Anazco, E Tama, A Acosta, ... Journal of the Endocrine Society 7 (Supplement_1), bvad114. 088, 2023 | | 2023 |
Diego Anazco VResearch Fellow, Mayo Clinic在 mayo.edu 的电子邮件经过验证
